EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Defense DEF

Pharmacy issues related to the annual defense authorization and implementation of the 2017 NDAA.

Contacted: Federal Trade Commission (FTC); Internal Revenue Service (IRS); Congressional Budget Office (CBO); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Labor, Dept of (DOL); White House Office; Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); SENATE; HOUSE OF REPRESENTATIVES; Office of Personnel Management (OPM); Executive Office of the President (EOP)

Taxation/Internal Revenue Code TAX

Implementation of tax provisions of the ACA, including the insurer tax. Tax reform policies.

Contacted: HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); Office of Personnel Management (OPM); White House Office; Internal Revenue Service (IRS); Labor, Dept of (DOL); Health Resources & Services Administration (HRSA); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); SENATE; Executive Office of the President (EOP)

Health Issues HCR

Regulatory policies related to the health reform law, including drug benefits and disclosure. Implementation of HITECH. Prescription drug affordability issues. Reforms to Medicaid and Exchange markets.

Contacted: Congressional Budget Office (CBO); Health & Human Services, Dept of (HHS); White House Office; Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Internal Revenue Service (IRS); Federal Trade Commission (FTC); SENATE; Labor, Dept of (DOL); Office of Personnel Management (OPM); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Government Accountability Office (GAO)

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing the Part D coverage gap, direct negotiation of prescription drug prices. Implementation of opioid abuse "lock in" provisions from CARA. Medicare Part B reforms. S. 637; HR 1920; HR 1939.

Contacted: HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Executive Office of the President (EOP); Medicare Payment Advisory Commission (MedPAC); Labor, Dept of (DOL); White House Office; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Internal Revenue Service (IRS); Office of Personnel Management (OPM); SENATE; Government Accountability Office (GAO)

Bills named: H.R. 1920 (115th), S. 637 (115th), H.R. 1939 (115th)

Pharmacy PHA

Design and coverage of pharmacy benefits in Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, EPCS, electronic prior authorization, PBM disclosure, MLR, and specialty pharmacy tiering. Implementation of biosimilars pathway from BPCIA. Policies placing restrictions on pharmacy benefit design. Issues relating to prescription drug affordability. REMS reform. Prescription drug user fee reauthorization. HR 1854; S. 788; HR 2025.

Contacted: Health Resources & Services Administration (HRSA); Congressional Budget Office (CBO); White House Office; SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Internal Revenue Service (IRS); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Labor, Dept of (DOL); Executive Office of the President (EOP); Federal Trade Commission (FTC); Office of Personnel Management (OPM)

Bills named: H.R. 2025 (115th), H.R. 1854 (115th), S. 788 (115th)